Retatrutide × Peptide Partners - Lab Test, April 2026
Test results
About this test
This independent LC-MS lab test confirms Retatrutide 24mg from Peptide Partners at 99.516% purity. The analysis was conducted by Trust Pointe Analytics on April 16, 2026.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. The tested quantity of 24.571mg demonstrates excellent consistency with the labeled 24mg across five vials, reflecting reliable synthesis. A purity level of 99.516% indicates minimal contamination and high-grade synthesis.
The full certificate of analysis is available for download on this page (Key: QPAMAFDFH38K).
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.